Skip to main content

EHMTI-0140. The potential role of levetiracetam in migraine treatment: an animal study

Introduction

Cortical spreading depression (CSD) is one of the most widely used animal models of migraine. Whether levetiracetam (LEV), like other antiepileptic drugs, has a role in the treatment of migraine remains uncertain.

Aim

To investigate the potential of LEV in the treatment of migraine using a rat model of CSD.

Method

Male Sprague-Dawley rats were used. The effects of acute (3 day) and chronic (28 days) treatment with vehicle, LEV 200mg/kg/d, and LEV 400mg/kg/d on CSD susceptibility were examined. Drugs were given as daily intraperitoneal injections. After completion of drug treatment, CSD was elicited by placing a cotton ball soaked with 1M KCl onto the occipital cortex, and was recorded for 2 hours by placing a glass microelectrode into the frontal cortex.

Results

In the acute treatment experiment, rats receiving LEV 400mg/kg/d (8.4±1.0) had fewer CSDs per hour than those receiving vehicle (12.9±1.7, p<0.001) and LEV 200mg/kg/d (12.5±1.2, p<0.001). In the chronic treatment experiment, rats receiving LEV 400mg/kg/d (11.4±0.6) had fewer hourly CSD events than those receiving vehicle (14.3±0.3, P<0.001) and LEV 200mg/kg/d (13.6±0.4, p<0.001), and rats treated LEV 200mg/kg/d had less CSDs than those in the vehicle group (p=0.049).

Conclusion

LEV had a modest effect on reducing CSD susceptibility at a dose of 400mg/kg/d, and the effects on CSD susceptibility were comparable when administered acutely or chronically.

Conflict of interest.

Author information

Affiliations

Authors

Corresponding author

Correspondence to YF Wang.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Yen, J., Kao, L. et al. EHMTI-0140. The potential role of levetiracetam in migraine treatment: an animal study. J Headache Pain 15, F30 (2014). https://doi.org/10.1186/1129-2377-15-S1-F30

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1129-2377-15-S1-F30

Keywords

  • Migraine
  • Frontal Cortex
  • Treatment Experiment
  • Antiepileptic Drug
  • Chronic Treatment